Gross Margin - Bioretec Oy (OMXH:BRETEC) - Alpha Spread
B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 2.68 EUR 0.37% Market Closed
Market Cap: 54.5m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Gross Margin
Bioretec Oy

69.8%
Current
71%
Average
47.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
69.8%
=
Gross Profit
2.7m
/
Revenue
3.9m

Gross Margin Across Competitors

Country FI
Market Cap 52.4m EUR
Gross Margin
70%
Country US
Market Cap 201.5B USD
Gross Margin
55%
Country US
Market Cap 171B USD
Gross Margin
67%
Country US
Market Cap 137.7B USD
Gross Margin
64%
Country US
Market Cap 121.5B USD
Gross Margin
69%
Country IE
Market Cap 113B USD
Gross Margin
66%
Country US
Market Cap 67.3B USD
Gross Margin
45%
Country DE
Market Cap 55.5B EUR
Gross Margin
38%
Country US
Market Cap 42.1B USD
Gross Margin
60%
Country US
Market Cap 41B USD
Gross Margin
77%
Country US
Market Cap 40.8B USD
Gross Margin
41%

Profitability Report

View the profitability report to see the full profitability analysis for Bioretec Oy.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
69.8%
=
Gross Profit
2.7m
/
Revenue
3.9m
What is the Gross Margin of Bioretec Oy?

Based on Bioretec Oy's most recent financial statements, the company has Gross Margin of 69.8%.